NHS Dudley Health Economy Medicines Formulary
Home > 8 Malignant disease and immunosuppression > 8.1 Cytotoxic drugs > 8.1.5 Other antineoplastic drugs > Bortezomib for previously untreated mantle cell lymphoma - NICE TAG TA370

Bortezomib for previously untreated mantle cell lymphoma - NICE TAG TA370

1.1 Bortezomib is recommended, within its marketing authorisation, as an option for previously untreated mantle cell lymphoma in adults for whom haematopoietic stem cell transplantation is unsuitable.

https://www.nice.org.uk/guidance/ta370

Site by Devopa
© Copyright 2021 NHS. All rights reserved.